Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue
October 26 2020 - 3:42PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Rick Doubleday,
Executive Vice President and Chief Commercial Officer, will retire
at the end of 2020 in order to spend more time with his family.
Rick joined Dexcom in 2009 and has built a world-class sales
organization that allowed Dexcom to grow from approximately $49
million in reported revenue in his first full year to its current
global commercial success. More importantly, through the efforts of
Rick and the many talented members of his sales leadership team,
the lives of countless people with diabetes have been improved by
Dexcom CGM technology. In order to support continued growth and
implementation of our commercial strategy, Mr. Doubleday will
continue as a consultant and will be actively engaged with the
Dexcom leadership team at least through 2021.
In conjunction with the announcement of Mr. Doubleday’s
retirement and to celebrate Rick’s accomplishments that include
another record quarter, the company today announced select
preliminary financial results for the third quarter ended September
30, 2020. Dexcom achieved half a billion dollars in revenue in the
third quarter, with revenues of $500.9 million, representing 26%
growth over the third quarter of 2019.
“Rick Doubleday has proven himself to be an extraordinary leader
throughout his time at Dexcom, which includes yet another record
result in the third quarter of 2020,” said Kevin Sayer, Dexcom’s
chairman, president and CEO. “During his tenure, Rick has not only
achieved outstanding results for our company, but has built and
established a world-class organization. I am thrilled for Rick to
spend more time with his family while continuing to assist Dexcom
as we further implement our growth initiatives.”
A full presentation of the company’s quarterly results will
occur at 1:30 PM PDT on Tuesday, October 27th. To listen to the
conference call, please dial (800) 447-0521 (US/Canada) or (847)
413-3238 (International) and use the confirmation number "49260065"
approximately five minutes prior to the start time.
About DexCom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through
innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, California, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom simplifies and improves
diabetes management around the world.
Cautionary Statement Regarding Forward Looking
Statements
This press release contains forward-looking statements that are
not purely historical regarding Dexcom’s or its management’s
intentions, beliefs, expectations and strategies for the future,
including those related to Dexcom’s expected revenue for the third
quarter of 2020 and growth rate over the third quarter of 2019. All
forward-looking statements included in this press release are made
as of the date of this release, based on information currently
available to Dexcom, deal with future events, are subject to
various risks and uncertainties, and actual results could differ
materially from those anticipated in those forward-looking
statements. The risks and uncertainties that may cause actual
results to differ materially from Dexcom’s current expectations are
more fully described in Dexcom’s Annual Report on Form 10-K for the
period ended December 31, 2019, as filed with the Securities and
Exchange Commission on February 13, 2020, and Quarterly Report on
Form 10-Q for the period ended June 30, 2020, as filed with the
Securities and Exchange Commission on July 28, 2020. Except as
required by law, Dexcom assumes no obligation to update any such
forward-looking statement after the date of this report or to
conform these forward-looking statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201026005877/en/
DexCom, Inc.: Steven R. Pacelli Executive Vice President,
Strategy and Corporate Development (858) 200-0200
www.dexcom.com
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2024 to May 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From May 2023 to May 2024